請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55896完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 潘子明(Tzu-Ming Pan) | |
| dc.contributor.author | Jui Kuo | en |
| dc.contributor.author | 郭睿 | zh_TW |
| dc.date.accessioned | 2021-06-16T05:10:21Z | - |
| dc.date.available | 2017-08-25 | |
| dc.date.copyright | 2014-08-25 | |
| dc.date.issued | 2014 | |
| dc.date.submitted | 2014-08-19 | |
| dc.identifier.citation | 李俊霖。2007。預防高血脂與阿茲海默症之多功效紅麴保健產品開發。國立臺灣大學生命科學院微生物與生化學研究所博士論文。台北。臺灣。中華民國。
陳彥霖。2003。紅麴中桔黴素之生成及安全性。食品工業，353(3): 30-37。 林讚峰。1995。紅麴菌培養工藝及紅麴應用之演進。製酒科技專論彙編。 17:156-168。 林讚峰。1983。紅麴菌的鑑定及實用分類法。製酒科技專論彙編。5:104-113。 行政院衛生福利部統計處。2014。http://www.mohw.gov.tw/cht/DOS/Statistic.aspx?f_list_no=312&fod_list_no=2747。 佐藤喜吉，1936。東洋產 Monascus 屬分類に對すゐ─ 考察。日農化會誌，12: 583-586。 蘇遠志、陳文亮、方鴻源、翁浩慶與王文祥。1970。紅麴菌（Monascus anka）之菌學研究。中國農業化學會誌，8:45-58。 玉田英明。1988。紅麴各種調味料之應用。食品及科學，July: 96-99。 Adams HP, Jr., Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, Kwiatkowski T, Lyden PD, Marler JR, Torner J, Feinberg W, Mayberg M, Thies W (1996) Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Circulation 94:1167-1174. Albers GW, Atkinson RP, Kelley RE, Rosenbaum DM (1995) Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Stroke 26:254-258. Allan SM, Rothwell NJ (2001) Cytokines and acute neurodegeneration. Nat Rev Neurosci 2:734-744. Aniya, Y., T. Yokomakura, M. Yonamine, K. Shimada, T. Nagamine, M. Shimabukuro and H. Gibo. 1999. Screening of antioxidant action of various molds and protection of Monascus anka against experimentally induced liver injuries of rats, Gen. Pharmacol. 32:225-231. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624. Berger, C., Xia, F., Maurer, M.H., Schwab, S., 2008. Neuroprotection by pravastatin in acute ischemic stroke in rats. Brain Res. Rev. 58, 48–56. Blanc, P. J., M.O. Loret, A.L. Santerre,A. Pareilleux, D. Prome, J.C. Prome, J.P. Laussac and G. Goma. 1994. Pigments of Monascus. J. Food Sci. 59:862-865. Bogousslavsky J, Van Melle G, Regli F (1988) The lausanne stroke registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19:1083-1092. Carden DL, Granger DN (2000) Pathophysiology of ischaemia-reperfusion injury. J Pathol 190:255-266. Chan PH (2001) Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2-14. Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., Katakowski, M., Lu, M., Chopp, M., 2005. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab. 25, 281–290. Choi DW (1996) Ischemia-induced neuronal apoptosis. Curr Opin Neurobiol 6:667-672. Chuang, C. Y.; Shi, Y. C.; You, H. P.; Lo, Y. H.; Pan, T. M. Antidepressant effect of GABA-rich Monascus-fermented product on forced swimming rat model. J. Agric. Food Chem. 2011, 59, 3027–3034 Clemens, J. A. (2000). Cerebral ischemia: gene activation, neuronal injury, and the protective role of antioxidants. Free Radic Biol Med 28: 1526-1531. Conroy BP, Black D, Lin CY, Jenkins LW, Crumrine RC, DeWitt DS, Johnston WE (1999) Lamotrigine attenuates cortical glutamate release during global cerebral ischemia in pigs on cardiopulmonary bypass. Anesthesiology 90:844-854. Davis SM, Albers GW, Diener HC, Lees KR, Norris J (1997) Termination of acute stroke studies involving selfotel treatment. ASSIST Steering Committed. Lancet 349:32. Durukan, A. and T. Tatlisumak (2007). Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87: 179-197. Eldadah BA, Faden AI (2000) Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 17:811-829. Endo A (1979) Monacolin-K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot 32:852–854 Fiskum G, Murphy AN, Beal MF (1999) Mitochondria in neurodegeneration: acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab 19:351-369. Hawksworth DL, Pit JI (1983) A new taxonomy for Monascusspecies based on cultural and microscopical characters. Aust J Bot 31:51–61 Hickenbottom SL, Grotta J (1998) Neuroprotective therapy. Semin Neurol 18:485-492. Ho, B. Y.; Pan, T. M. The Monascus metabolite monacolin K reduces tumor progression and metastasis of Lewis lung carcinoma cells. J. Agric. Food Chem. 2009, 57, 8258–8265. Hsu, W.H., Lee, B.H., Pan, T.M., 2011. Effects of red mold dioscorea on oral carcinogenesis in DMBA-induced hamster animal model. Food Chem. Toxicol. 49, 1292–1297. Hsu WH, Liao TH, Lee BH, Hsu YW, Pan TM (2013) Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-fat diet via PPAR-gamma activation. J Funct Foods 5:124–132 Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA (1994) Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265:1883-1885. Huang, Z.B.; Xu, Y.; Li, L.S.; Li, Y.P. Two new Monascus metabolites with strong blue fluorescence isolated from red yeast rice. J. Agr. Food Chem. 2008, 56, 112-118. Iizuka, H. and C. F. Lin. 1980. On the genus Monascus of Asia and its specific characteristics. Advances in Biotechnol. 2：555∼561. Infeld B, Davis SM, Donnan GA, Yasaka M, Lichtenstein M, Mitchell PJ, Fitt GJ (1999) Nimodipine and perfusion changes after stroke. Stroke 30:1417-1423. Iwasaki Y, Ito S, Suzuki M, Nagahori T, Yamamato T, Konno H (1989) Forebrain ischemia induced by temporary bilateral common carotid occlusion in normotensive rats. J Neurol Sci 90:155–165. Jiwa NS, Garrard P, Hainsworth AH. Experimental models of vascular dementia and vascular cognitive impairment: a systematic review. J Neurochem 2010;115: 814–828. Juzlova, P., L. Martinkova and V. Kren. 1996. Secondary metabolites of the fungus Monascus: a review, J. Ind. Microbiol. 16:163-170. Klijn, C. J. and G. J. Hankey (2003). Management of acute ischaemic stroke: new guidelines from the American Stroke Association and European Stroke Initiative. Lancet Neurol 2: 698-701. Kohama, Y., Matsumoto, S., Mimura, T., Tanabe, N., Inada, A. and Nakanishi, T. (1987) Isolation and identification of hypotensive principles in red-mold rice. Chem Pharm Bull (Tokyo) 35: 2484-2489. Krajewski S, Krajewska M, Ellerby LM, Welsh K, Xie Z, Deveraux QL, Salvesen GS, Bredesen DE, Rosenthal RE, Fiskum G, Reed JC (1999) Release of caspase-9 from mitochondria during neuronal apoptosis and cerebral ischemia. Proc Natl Acad Sci USA 96:5752-5757. Lapchak PA (2006) 3Alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator. Exp Neurol 197:531-537. Lee BH, Hsu WH, Chang YY, Kuo HF, Hsu YW, Pan TM (2012) Ankaflavin: a natural novel PPARgamma agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free Radic Biol Med 53:2008–2016 Lee CL, Wang JJ, Kuo SL, Pan TM (2006) Monascus fermentation of dioscorea for increasing the production of cholesterol-lowering agent—monacolin K and antiinflammation agent—monascin. Appl Microbiol Biotechnol 72:1254–1262. Lee, C.L., Wang, J.J., Pan, T.M., 2008. Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and anti-oxidative effect. Appl. Microb. Biotechnol. 79, 829–841. Lefer, D. J. (2002) Statins as potent antiinflammatory drugs. Circulation 106: 2041-2042. Leker RR, Shohami E (2002) Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Rev 39:55-73. Marti, H. J., Bernaudin, M., Bellail, A., Schoch, H., Euler, M., Petit, E. et al. (2000). Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156: 965–976. Montaner, J., Chacon, P., Krupinski, J., Rubio, F., Millan, M., Molina, C.A., Hereu, P., Quintana, M., varez-Sabin, J., 2008. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. Eur. J. Neurol. 15, 82–90. Moskowitz MA (1998) Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci 18:3659-3668. Murphy AN, Fiskum G, Beal MF (1999) Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb Blood Flow Metab 19:231-245. Namura S, Zhu J, Fink K, Endres M, Srinivasan A, Tomaselli KJ, Yuan J, Petito CK, Halaby IA (1993) Relationship between ischemia and ischemic neuronal necrosis to astrocyte expression of glial fibrillary acidic protein. Int J Dev Neurosci 11:239–247 Qayumi AK, English JC, Godin DV, Ansley DM, Loucks EB, Lee JU, Kim CW (1998) The role of platelet-activating factor in regional myocardial ischemia-reperfusion injury. Ann Thorac Surg 65:1690-1697. Silver, J. and Miller J. H. (2004). Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146-156. Steiner T, Hacke W (1998) Combination therapy with neuroprotectants and thrombolytics in acute ischaemic stroke. Eur Neurol 40:1-8. Suits, E. and R. L. Isaacson (1968). The effects of scopolamine hydrobromide on one-way and two-way avoidance learning in rats. Int J Neuropharmacol 7: 441-446. Taira, J., C. Miyagi, Y. Aniya. 2002. Dimerumic acid as an antioxidant from the mold, Monascus anka: the inhibition mechanism against lipid peroxidation and hemeprotein-meduated oxidation, Biochemical pharmacology. 65:1019-1026. Tarozzo G, Campanella M, Ghiani M, Bulfone A, Beltramo M: Expression of fractalkine and its receptor, CX3CR1, in response to ischemia-reperfusion brain injury in the rat. Eur J Neurosci 15: 1663-1668. Traystman, R.J. (2003). Animal models of focal and global cerebral ischemia. ILAR journal / National Research Council, Institute of Laboratory Animal Resources 44, 85-95. Tsuji, K., Tsuji, E., Nakagawa, Y. and Suzuki, S. (1988). Effect of the sodium absorption capacity of dietary fiber on blood pressure of spontaneously hypertensive rats. Nihon Kasei Gakkaishi, 39, 187-195 (in Japanese). U.S. Food and Drug Administration. Guidance for Industry-computerized systems used in clinical trials. www.fda.gov/ora/compliance_ref/bimo/ffinalcct.htm Date last updated: January 1, 1997. Date last accessed:November 30, 2007. Van der Most, P. J., Dolga, A. M., Nijholt, I. M., Luiten, P. G., and Eisel, U. L. (2009). Statins: mechanisms of neuroprotection. Prog. Neurobiol. 88, 64–75. Vaughan CJ, Delanty N. Neuroprotective properties of statins in cerebral ischemia and stroke. Stroke. 1999;30:1969–1973. Wahlgren NG, Ranasinha KW, Rosolacci T, Franke CL, van Erven PM, Ashwood T, Claesson L (1999) Clomethiazole acute stroke study (CLASS): results of a randomized, controlled trial of clomethiazole versus placebo in 1360 acute stroke patients. Stroke 30:21-28. Widmaier EP. Chapter 4 Structure of the Nervous System. Textbook-Human physiology (Mc Graw Hill Book Publishing Co.).2006;4:122-136. Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, et al. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]- 2(3H)-one (ZSET14460), on learning impairments induced by amyloid-1–40 in the rat. J Pharmacol Exp Ther 2006;317:1079–87. Yamori, Y., Horie R., et al. (1976). Pathogenetic similarity of strokes in stroke-prone spontaneously hypertensive rats and humans. Stroke 7: 46-53. Yasukawa, K., M. Takahashi, S. Natori, M. Yamazaki, M. Takeuchi, M. Takido. 1994. Azaphilones inhibit tumor promotion by 12-o-tetradecanoylphorbol-13-acetate, Oncology. 45:108-112. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/55896 | - |
| dc.description.abstract | 腦中風再灌流 (cerebral stroke reperfusion) 之傷害過程包含氧化壓力產生、引發細胞凋亡等，本研究使用八週齡大之雄性 Sprague-Dawley 大鼠，以雙側總頸動脈阻斷再灌流之手術引發腦中風，造成學習記憶能力之衰退，而紅麴米萃取物及二次代謝物 lovastatin 能有效改善大鼠記憶功能損傷。腦中風使大鼠腦中之 glial fibrillary acidic protein (GFAP) 表現量增加，而紅麴米萃取物及二次代謝物 lovastatin 能降低其表現，另外亦能降低腦中氧化壓力及凋亡現象，對照劑 melatonin 也加入評估，而效果不顯著。本研究結果顯示紅麴能增加抗氧化酵素活性並減少malondialdehyde (MDA) 之產生，抑制凋亡現象及降低 GFAP 表現，而最後改變腦中風造成之記憶學習能力損傷，且效果較 melatonin佳。證明紅麴米萃取物及二次代謝物 lovastatin 能夠延緩並改善腦中風之病理狀況。 | zh_TW |
| dc.description.abstract | Oxidative stress and apoptosis induced from cerebral stroke-reperfusion are involved in the cerebral stroke and reperfusion processes of impairment. In this research, every male Sprague-Dawley rats accept bilateral common carotid artery occlusion-reperfusion operation to induce memory and learning ability impairment of stroke. We examined the beneficial effects of the extract and secondary metabolite of red mold rice (RMR) in this model. The extract and secondary metabolite of RMR could improve cognitive impairment in behavior tests. We also found that extract and secondary metabolite of RMR reduce the expression of red mold rice glial fibrillary acidic protein (GFAP) which is elevated by stroke. Furthermore, the extract and secondary metabolite of RMR could reduce oxidative stress and apoptosis in rat’s brain. Effects of melatonin, as a contrast agent, was also examined in this research and show no significant improvement. This research shows that by suppressing lipid peroxidation and activating antioxidant enzyme, the extract and secondary metabolite of RMR could reduce oxidative stress and apoptosis and then ameliorates stroke pathology finally. Thus, protects rats against the impairment of memory and learning ability induced by stroke. In addition, these advantageous effects of the extract and secondary metabolite of RMR on stroke are even better than melatonin. This research proves that the extract and secondary metabolite of RMR could protect the brain from stroke and have multifunctional property in stroke treatment. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-16T05:10:21Z (GMT). No. of bitstreams: 1 ntu-103-R00b22034-1.pdf: 2972650 bytes, checksum: 3dec6a6e949ba08f9ad5ac031c422ce3 (MD5) Previous issue date: 2014 | en |
| dc.description.tableofcontents | 目 錄
縮寫表…………………………………………………………………………………………………………………………. i 中文摘要…………………………………………………………………………………………………………………….. iii 英文摘要……………………………………………………………………………………………………………………… iv 目錄…………………………………………………………………………………………………………………………….. v 圖目錄…………………………………………………………………………………………………………………………. vii 第壹章 文獻回顧…………………………………………………………………….….……………………………… 1 一、腦中風…………………………………………………………………………………………………………………. 1 (一) 腦中風之簡介……………………………………………………………………………………………………. 1 (二) 腦中風之病理機制……………………………………………………………………………………………. 3 (三) 腦中風之動物模式……………………………………………………………………………………………. 6 (四) 現行腦中風之治療方式…………………………………………………….……………………………… 9 二、紅麴……………………………………………………………………………………………………………………… 11 (一) 紅麴菌種之特性……………………………………………………………………………………………….. 11 (二) 紅麴之二次代謝物及功效…………………………………………………………………………………. 12 (三) 紅麴與腦中風……………………………………………………………………………………………………. 15 第二章 研究動機與大綱…………………………………………………………………….……………………… 17 第三章 材料與方法……………………………………………………………………………………………………. 19 ㄧ、實驗材料……………………………………………………………………………………………………………… 19 (一) 儀器…………………………………………………………………………………………………………………… 19 (二) 藥品…………………………………………………………………………………………………………………… 19 二、實驗方法……………………………………………………………………………………………………………… 20 (一) 動物實驗…………………………………………………………………………………………………………... 20 (二) 生化分析…………………………………………………………………………………………………………… 30 (三) 統計分析方法……………………………………………………………………………………………………. 32 第四章 結果與討論……………………………………………………………………………………………………. 33 ㄧ、實驗動物之飼養與生長狀況………………………………………………………………………………. 33 二、以雙側總頸動脈阻斷 30 分鐘再灌流手術誘導腦中風……………………………………. 33 三、紅麴米萃取物對腦中風大鼠學習記憶能力之改善……………………………………………. 33 四、紅麴米萃取物對腦中風大鼠病理狀況之改善效果………………………………………….. 42 五、綜合討論……………………………………………………………………………………………………………. 50 第五章 總結……………………………………………………………………………………………………………….. 53 第六章 參考文獻………………………………………………………………………………………………………… 54 | |
| dc.language.iso | zh-TW | |
| dc.subject | 再灌流 | zh_TW |
| dc.subject | 水迷宮 | zh_TW |
| dc.subject | 被動迴避 | zh_TW |
| dc.subject | 紅麴 | zh_TW |
| dc.subject | 中風 | zh_TW |
| dc.subject | water maze | en |
| dc.subject | passive avoidance | en |
| dc.subject | stoke | en |
| dc.subject | reperfusion | en |
| dc.subject | red mold | en |
| dc.title | 紅麴發酵產物改善腦中風大鼠記憶學習能力效果之研究 | zh_TW |
| dc.title | Effects of red mold fermented product to improve memory and learning ability on stroke rats | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 102-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.coadvisor | 郭宗甫(Tzong-Fu Kuo) | |
| dc.contributor.oralexamcommittee | 蕭勝煌(Sheng-Huang Hsiao),李俊霖(Chun-Lin Lee),林?輝(Feng-Huei Lin) | |
| dc.subject.keyword | 中風,紅麴,再灌流,水迷宮,被動迴避, | zh_TW |
| dc.subject.keyword | stoke,red mold,reperfusion,water maze,passive avoidance, | en |
| dc.relation.page | 60 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2014-08-19 | |
| dc.contributor.author-college | 生命科學院 | zh_TW |
| dc.contributor.author-dept | 生化科技學系 | zh_TW |
| 顯示於系所單位： | 生化科技學系 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-103-1.pdf 未授權公開取用 | 2.9 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。